Main Article Content

Abstract

Leptin is a 16 kDa adipocyte-secreted hormone that regulates weight centrally and links nutritional status to neuroendocrine and immune functions. Several studies indicate that leptin plays an important role in immune responses. Leptin affects both innate and adaptive immunity. It can stimulate dendritic cells (DC), monocytes, macrophages, neutrophils and natural killer cells. Leptin is involved in DC maturation and survival,
and can skew the cytokine balance of a T helper (Th)1 profi le. In adaptive immunity, leptin can promote naïve T cell survival and production of interferon-γ and interleukin-2, and activate Th1 cells while inhibiting Th2 cells. Leptin may play an important role in the
regulation of the Th1/Th2 balance. As a survival factor, leptin has been shown to suppress B cell apoptosis. The role of leptin in the pathogenesis of systemic lupus
erythematosus (SLE) is not fully determined yet. This review tries to link the role of leptin in immunity to the pathogenesis of SLE.

Article Details

How to Cite
Suarjana, I. N. (2018). Role of leptin in the pathogenesis of systemic lupus erythematosus. Indonesian Journal of Rheumatology, 1(1). https://doi.org/10.37275/ijr.v1i1.12

References

  1. Garcia-Gonzales A, Gonzales-Lopez L, Valera-Gonzales IC, Cardona-
  2. Munoz EG, Salazar-Paramo M, Gonzales-Ortiz M, et al. Serum leptin
  3. levels in women with systemic lupus erythematosus. Rheumatol Int
  4. ;22:138-141.
  5. Karmiris K, Koutroubakis IE, Kouroumalis EA. The emerging role of adipocytokines as infl ammatory mediators in infl ammatory bowel disease. Infl amm Bowel Dis 2005;11:847-855.
  6. Faggioni R, Feingold KR, Grunfeld C. Leptin regulation of the immune
  7. response and the immunodefi ciency of malnutrition. FASEB J 2001; 15: 2565-2571.
  8. Huising MO, Kruiswijk CP, Flik G. Phylogeny and evolution of class-I
  9. helical cytokines. J Endocrinol 2006;189:1-25.
  10. Lam QL, Lu L. Role of leptin in immunity. Cell Mol Immunol 2007;4(1):1-
  11. Silva C, Isenberg DA. Aetiology and pathology of systemic lupus erythematosus. Hospt Pharm 2001; 7:1-7.
  12. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003; 56:481-490
  13. Manson JJ, Isenberg DA. The Pathogenesis of systemic lupus erythematosus. J Netherl Med 2003;61(11):343-346.
  14. Zvezdanovic L, Dordevic V, Cosic V, Cvetkovic T, Kundalic S, Stankovic
  15. A. The signifi cance of cytokines in diagnosis of autoimmune diseases.
  16. Jugoslov Med Biohem 2006;25:363-372.
  17. Otero M, Lago R, Gomez R, Dieguez C, Lago F, Gomez-Reino J,
  18. Gualillo O. Towards a pro-infl ammatory and immunomodulatory
  19. emerging role of leptin. Rheumatol 2006;45:944-950.
  20. Bernotiene E, Palmer G, Gabay C. The role of leptin in innate and
  21. adaptive immune responses. Arthritis Res Ther 2006;8:217-226.
  22. Matarese G, Moschos S, Mantzoros C. Leptin in immunology. J
  23. Immunol 2005;173:3137-3142.
  24. Lavens D, Montoye T, Piessevaux J, Zabeau L, Vandekerckhove J, Gevaert K, et al. A complex interaction pattern of CIS and SOCS2 with
  25. the leptin receptor. J Cell Sci 2006;119:2214-2224.
  26. Bartek J, Stejskal D,Stejskal P, Oral I. Concentration of soluble leptin
  27. in population. Acta Univ Palacki Olomuc Fac Med 2000;144:7-9.
  28. Hekerman P, Zeidler J, Bamberg-Lemper S, Knobelspies H ,
  29. Lavens D, Tavernier J , et al. Pleiotropy of leptin receptor signalling is defined by distinct roles of the intracellular tyrosines. FEBS J
  30. ;272(1):109-119.
  31. Munzberg H, Bjornholm M, Bates SH, Myers MG Jr. Leptin receptor
  32. action and mechanisms of leptin resistance. Cell Mol Life Sci
  33. ;62:642-652.
  34. Banks AS, Davis SM, Bates SH, Myers MG Jr. Activation of downstream signals by the long form of the leptin receptor. J Biol Chem 2000; 275: 14563-14572.
  35. van den Brink GR, O’Toole T, Hardwick JC, van den Boogaardt DE,
  36. Versteeg HH, van Deventer SJ, Peppelenbosch MP. Leptin signaling
  37. in human peripheral blood mononuclear cells, activation of p38 and
  38. p42/44 mitogen-activated protein (MAP) kinase and p70 S6 kinase.
  39. Mol Cell Biol Res Commun 2000;4(3):144-150.
  40. Bjorbaek C, Buchholz RM, Davis SM, Bates SH, Pierroz DD, Gu H, et
  41. al. Divergent roles of SHP-2 in ERK activation by leptin receptors. J
  42. Biol Chem 2001;276:4747-4755.
  43. Tartaglia LA. The leptin receptor. J Biol Chem 1997;272:6093-6096.
  44. Belouzard S, Rouille Y. Ubiquitylation of leptin receptor OB-Ra regulates its clathrin-mediated endocytosis. EMBO J 2006;25:932-
  45. Martin-Romero C, Sanchez-Margalet V. Human leptin activates PI3K
  46. and MAPK pathways in human peripheral blood mononuclear cells :
  47. possible role of Sam68. Cell Immunol 2001;212:83-91.
  48. Rosenblum CI, Tota M, Cully D, Smith T, Collum R,Qureshi S, et al.
  49. Functional STAT 1 and STAT 3 signaling by the leptin receptor (OB-R);
  50. reduced expression of the rat fatty leptin receptor in transfected cells.
  51. Endocrinology 1996;137:5178-5181.
  52. Wang Y, Kuropatwinski KK, White DW, Hawley TS, Hawley RG,
  53. Tartaglia LA, et al. Leptin receptor action in hepatic cells. J Biol Chem
  54. ;272:16216-16223.
  55. Cui H, Cai F, Belsham DD. Leptin signaling in neurotensin neurons
  56. involves STAT, MAP kinases ERK1/2, and p38 through c-Fos and
  57. ATF1. FASEB J 2006;20:2654-2656.
  58. Mansour E, Pereira FG, Araujo EP, Amaral MEC, Morari J, Ferraroni
  59. NR, et al. Leptin inhibits apoptosis in thymus through a janus kinase-
  60. -independent, insulin receptor substrate-1/phosphatidylinositol-3
  61. kinase-dependent pathway. Endocrinology 2006;147:5470-5479.
  62. Papathanassoglou E, El-Haschimi K, Li XC, Matarese G, Strom T,
  63. Mantzoros C. Leptin receptor expression and signaling in lymphocytes:
  64. kinetics during lymphocyte activation, role in lymphocyte survival, and
  65. response to high fat diet in mice. J Immunol 2006;176:7745-7752.
  66. Sanchez-Margalet V, Martin-Romero C. Human leptin signaling in
  67. human peripheral blood mononuclear cells: activation of the JAKSTAT
  68. pathway. Cell Immunol 2001;211:30-36.
  69. O’Rourke L, Yeaman SJ, Shepherd PR. Insulin and leptin acutely
  70. regulate cholesterol ester metabolism in macrophages by novel
  71. signaling pathways. Diabetes 2001;50:955-961.
  72. Najib S, Rodriguez-Bano J, Rios MJ, Muniain MA, Goberna R,
  73. Sanchez-Margalet V. Sam68 is tyrosine phosphorylated and recruited
  74. to signaling in peripheral blood mononuclear cells from HIV infected
  75. patients. Clin Exp Immunol 2005;141:518-525.
  76. Bjorbak C, Lavery HJ, Bates SH, Olson RK, Davis SM, Flier JS, Myers
  77. MG, Jr. SOCS3 mediates feedback inhibition of the leptin receptor via
  78. Tyr985. J Biol Chem 2000;275:40649-40657.
  79. Dunn SL, Bjornholm M, Bates SH, Chen Z, Seifert M, Myers MG,Jr.
  80. Feedback inhibition of leptin receptor/Jak2 signaling via Tyr1138 of the
  81. leptin receptor and suppressor of cytokine signaling 3. Moll Endocrinol
  82. ;19:925-938.
  83. Greenhalgh CJ, Metcalf D, Thaus AL, Corbin JE, Uren R, Morgan
  84. PO, et al.Biological evidence that SOCS-2 can act either as an
  85. enhancer or suppressor of growth hormone signaling. J Biol Chem
  86. ;277:40181-40184.
  87. Sahu A. Leptin signaling in the hypothalamus: emphasis on
  88. energy homeostasis and leptin resistance. Front Neuroendocrinol
  89. ;24:225-253.
  90. Zobolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang
  91. Y, Minokoshi Y, et al. PTP1B regulates leptin signal transduction in
  92. vivo. Dev Cell 2002;2:489-495.
  93. Kaszubska W, Falls HD, Schaefer VG, Haasch D, Frost L, Hessler
  94. P, et al. Protein tyrosine phosphatase 1B negatively regukates leptin
  95. signaling in a hypothalamic cell line. Mol Cell Endocrinol 2002;195:109-
  96. Myers MG, Jr. Leptin receptor signaling and the regulation of
  97. mammalian physiology. Recent Prog Horm Res 2004;50:287-304.
  98. Takekoshi K, Ishii K, Nanmoku T, Shibuya S, Kawakami Y, Isobe
  99. K, Nakai T. Leptin stimulates catecholamine synthesis in a PKCdependent
  100. manner in cultured porcine adrenal medullary chromaffi n
  101. cells. Endocrinology 2001;142:4861-4871.
  102. Lappas M, Permezel M, Rice GE. Leptin and adiponectin stimulate
  103. the release of proinfl ammatory cytokines and prostaglandins from
  104. human placenta and maternal adipose tissue via nuclear factor-κB,
  105. peroxisomal proliferator-activated receptor-γ and extra-cellularly
  106. regulated kinase 1/2. Endocrinology 2005;146:3334-3342.
  107. Montecucco F, Bianchi G, Gnerre P, Bertolotto M, Dallegri F, Ottonello
  108. L. Induction of neutrophil chemotaxis by leptin: crucial role for p38 and
  109. Src kinases. Ann N Y Acad Sci 2006;1069:463-471.
  110. Shen J, Sakaida I, Uchida K, Terai S, Okita K. Leptin enhances TNF-α
  111. production via p38 and JNK MAPK in LPS-stimulated Kupffer cells.
  112. Life Sci 2005;77:1502-1515.
  113. Sanchez-Margalet V, Martin-Romero C, Santos-Alvares J, Goberna R,
  114. Najib S, Gonzalez-Yanes C. Role of leptin as an immunomodulator of
  115. blood mononuclear cells. Clin Exp Immunol 2003;133:11-19.
  116. Luft T, Maraskovsky E, Schnurr M, Knebel K, Kirsch M, Gorner M, et al.
  117. Tuning the volume of the immune response: strength and persistence
  118. of stimulation determine migration and cytokine secretion of dendritic
  119. cells. Blood 2004;104:1066-1074.
  120. Marzio PD, Sherry B, Thomas EK, Franchin G, Schmidtmayerova H,
  121. Bukrinsky M. β-Chemokine production in CD40L-stimulated monocytederived
  122. macrophages requires activation of MAPK signaling pathways.
  123. Cytokine 2003;23:53-63.
  124. Ozata M, Ozdemir IC, Licinio J. Human leptin defi ciency caused by a
  125. missense mutation: multiple endocrine defects, decreased sympathetic
  126. tone, and immune system dysfunction indicate new targets for leptin
  127. action, greater central than peripheral resistance to the effects of
  128. leptin, and spontaneous correction of leptin-mediated defects. J Clin
  129. Endocrinol Metab 1999;84:3686-3695.
  130. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C,
  131. et al. Benefi cial effects of leptin on obesity, T cell hyporesponsiveness,
  132. and neuroendocrine/metabolic dysfunction of human congenital leptin
  133. defi ciency. J Clin Invest 2002;110:1093-1103.
  134. Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Fiengold
  135. KR, Grunfeld C. Leptin defi ciency enhances sensitivity to endotoxininduced
  136. lethality. Am J Physiol. 1999;276:R136-R142.
  137. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, et
  138. al. Leptin regulates proinfl ammatory immune responses. FASEB J
  139. ;12:57-65.
  140. Santoz-Alvarez J, Goberna R, Sanchez-Margalet V. Human leptin
  141. stimulates proliferation and activation of human circulating monocytes.
  142. Cell immunol 1999;194:6-11.
  143. Lam QL, Liu S, Cao X, Lu L. Involvement of leptin signaling in the
  144. survival and maturation of bone marrow-derived dendritic cells. Eur J
  145. Immunol 2006;36:3118-3130.
  146. Mattioli B, Straface E, Quaranta MG, Giordani L, Viora M. Leptin
  147. promotes differentiation and survival of human dendritic cells and
  148. licenses them for Th1 priming. J Immunol 2005;174:6820-6828.
  149. Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lucas NW,
  150. Huffnagle GB. Leptin-defi cient mice exhibit impaired host defence in
  151. gram-negative pneumonia. J Immunol 2002;168:4018-4024.
  152. Dixit VD, Mielenz M, Taub DD, Parvizi N. Leptin induces growth
  153. hormone secretion from peripheral blood mononuclear cells
  154. via a protein kinase C- and nitric oxide-dependent mechanism.
  155. Endocrinology 2003;144:5595-5603.
  156. Zarkesh-Esfahani H, Pockley G, Metcalfe RA, Bidlingmaier M, Wu
  157. Z, Ajami A, et al. High-dose leptin activates human leukocytes via
  158. receptor expression on monocytes. J Immunol 2001;167:4593-4599.
  159. La Cava A, Matarese G. The weight of leptin in immunity. Nature Rev
  160. ;4:371-379.
  161. Caldefi e-Chezet F, Poulin A, Tridon A, Sion B, Vasson MP. Leptin:
  162. a potential regulator of polymorphonuclear neutrophil bactericidal
  163. action? J Leukoc Biol 2001;69:414-418.
  164. Zarkesh-Esfahani H, Pockley AG, Wu Z, Hellewell PG, Weetman AP,
  165. Ross RJM. Leptin indirctly activates human neutrophils via induction
  166. of TNF-α. J Immunol 2004;172:1809-1814.
  167. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI.
  168. Leptin modulates the T-cell immune response and reverses starvationinduced
  169. immunosuppression. Nature 1998;394:897-901.
  170. Zhao Y, Sun R, You L, Gao C, Tian Z. Expression of leptin receptors
  171. and response to leptin stimulation of human natural killer cell lines.
  172. Biochem Biophys Res Commun 2003;300:247-252.
  173. Bennet BD, Solar GP, Yuan JQ, Mathias J, Thomas GR, Matthews W.
  174. A role for leptin and its cognate receptor in hematopoiesis. Curr Biol
  175. ;6:1170-1180.
  176. Hick RW, Gruver AL, Ventevogel MS, Haynes BF, Sempowski GD.
  177. Leptin selectively augments thymopoiesis in leptin defi ciency and
  178. lipopolysaccharide-induced thymic atrophy. J Immunol 2006;177:169-
  179. Fujita Y, Murakami M, Ogawa Y, Masuzaki H, Tanaka M, Ozaki S, et
  180. al. Leptin inhibits stress-induced apoptosis of T lymphocytes. Clin Exp
  181. Immunol 2002;128:21-26.
  182. Shimabukuro M, Wang MY, Zhou YT, Newgard CB, Unger RH.
  183. Protection against lipoapoptosis of beta cells through leptindependent
  184. maintenance of Bcl-2 expression. Proc Natl Acad Sci USA
  185. ;95:9558-9561.
  186. Busso N, So A, Chobaz-Peclat V, Morard C, Martinez-Soria E, Talabot-
  187. Ayer D, Gabay C. Leptin signaling defi ciency impairs humoral and
  188. cellular immune responses and attenuates experimental arthritis. J
  189. Immunol 2002;168:875-882.
  190. Howard JK, Lord GM, Matarese G, Vendetti S, Ghatei MA, Ritter
  191. MA, et al. Leptin protects mice from starvation-induced lymphoid
  192. atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest
  193. ;104(8):1051-1059.
  194. Martin-Romero C, Santos-Alvarez J, Goberna R, Sanchez-Margalet
  195. V. Human leptin enhances activation and proliferation of human
  196. circulating T lymaphocytes. Cell Immunol 2000;199:15-24.
  197. Matarese G, Giacomo A, Sanna V, Lord GM, Howard JK, Tuoro
  198. AD, et al. Requirement for leptin in the induction and progession of
  199. autoimmune encephalomyelitis. J Immunol 2001;166:5909-5916.
  200. Matarese G, Sanna V, Lecher RI, Sarvetnick N, Fontana S, Zappacosta
  201. S, La Cava A. Leptin accelerates autoimmune diabetes in female NOD
  202. mice. Diabetes 2002;51:1356-1361.
  203. De Rosa V, Procaccini C, La Cava A, Chieffi P, Nicoletti GF, Fontana S,
  204. et al. Leptin neutralization interferes with pathogenic T cell autoreactivity
  205. in autoimmune encephalomyelitis. J Clin Invest 2006;116:447-455.
  206. Bernotiene E, Plamer G, Talabot-Ayer D, Szalay-Quinodoz I, Aubert
  207. ML, Gabay C. Deleyed resolution of acute infl ammation during
  208. zymosan-induced arthritis in leptin-defi cient mice. Arthritis Res Ther
  209. ;6:R256-R263.
  210. Matarese G, Sanna V, Di Giacomo A, Lord GM, Howard JK, Bloom S,
  211. et al. Leptin potentiates experimental autoimmune encephalomyelitis
  212. in SJL female mice and confers susceptibility to males. Eur J Immunol
  213. ;31:1324-1332.
  214. Siegmund B, Lear-Kaul KC, Faggioni R, Fantuzzi G. Leptin defi ciency,
  215. not obesity, protecs mice from Con A-induced hepatitis. Eur J Immunol
  216. ;32:552-560.
  217. Tarzi RM, Cook HT, Jackson I, Pusey CD, Lord GM. Leptin-defi cient
  218. mice are protected from accelerated nephrotoxic nephritis. Am J
  219. Pathol 2004;164:385-390.
  220. Matarese G, Sanna V, Fontana S, Zappacosta S. Leptin as a novel
  221. therapeutic target for immune intervention. Currt Drug Targ infl am
  222. Allerg 2002;1:13-22.
  223. Wislowska M, Rok M, stepien K, Kuklo-Kowalska A. Serum leptin in
  224. systemic lupus erythematosus. Rheumatol Int 2008;28:467-473.
  225. Gayed M, Gordon C. Pregnancy and rheumatic diseases.
  226. Rheumatology 2007;46:1634-1640.